Details of Bacterial Vaccine
This bacterial vaccine card gives comprehensive information about each vaccine.
Detailed Information | |
---|---|
ID | 1234 |
Name of the vaccine | CDIFF Ag |
Microbe | Bacteria |
Disease name | Clostridium Difficile Infection |
Name of bacteria | Clostridium difficile |
Type of vaccine | Recombinant |
Nucleic acid content | Linear DNA |
Age | 18 to 70 years |
Description of the vaccine | Vaccine based on the F2 antigen(GSK2904545A). |
Name of the manufacturer | GlaxoSmithKline |
Name of the manufacturing country | Belgium |
Year of manufacture | 2022 |
Clinical Phase status | Clinical - Phase 1 |
Bacterial strain | Gram-positive bacillus. |
Efficacy | NA |
Vaccine formulation | Suspension for injection |
Dosage | Two doses of 0.5 mL. |
Mechanism of action | NA |
Route of administration | Intramuscular |
Indications | Prevention of the primary C. Diff diseases and recurrences. |
Export | NA |
Approval | NA |
Adjuvant | AS01B |
Repurposing | NA |
Side effects of vaccine | NA |
Post vaccination | NA |
Dose type | Combination (2 doses) |
Interspecies transfer | NA |
PubMed identifier | NA |
Clinical trial number | NCT04026009 |
Reference | https://www.gsk.com/en-gb/research-and-development/our-pipeline/ |
Other name | NA |
Additional Links | NA |